Articles

Boehringer Ingelheim Completes Plant Expansion After $76 Million Georgia Investment

DULUTH, Ga., Oct. 9, 2019 /PRNewswire/ — Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76 millioninvestment in its site in Athens, Ga. The investment doubled the company’s capacity to produce vaccines for pets in the United Statesand around the world. “Today’s announcement is representative of the growth…

Read More

Biotechnology Innovation Organization Announces 2021 Leadership Transition

The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new leader to represent the industry globally and to defend innovation from domestic political attacks. Biotechnology Innovation Organization Announces 2021 Leadership Transition…

Read More

Historic NIH research grants to UGA, Emory could exceed $200 million

Funding validates GRA’s Eminent Scholar model This week’s news that the National Institutes of Health (NIH) has awarded two Georgia universities major grants to advance work toward a universal flu vaccine is more than a testament to their sophisticated research programs. It also reflects how the Georgia Research Alliance’s efforts to recruit world-class scientists to Georgia…

Read More

NIH awards up to $130M for flu vaccine development to University of Georgia

UGA to lead effort aimed at protecting vulnerable populations The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to…

Read More

Georgia Bio to Showcase State’s Leadership and Patients’ Perspectives in Bioscience Innovation at 2019 Innovation Summit

The Georgia Bio Innovation Summit is the southeast’s largest life science conference, showcasing Georgia’s leadership in innovation to improve the health and well-being of people, animals and the environment. This year’s Summit will bring together hundreds of CEOs, senior executives, scientists and public policy officials from Georgia and across the nation on October 8 at the Cobb Galleria in Atlanta.

Read More

AdvaMed, MITA, MDMA and a Broad Coalition of Stakeholders Urge Congress to Permanently Repeal the Medical Device Tax

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA), the Medical Imaging & Technology Alliance (MITA) and a broad coalition of medical innovators, physician inventors, patient groups, and others sent a letter to congressional leadership today urging them to permanently repeal the medical device excise tax. “The United States is…

Read More

Georgia Research Alliance gets Kemp’s backing

Gov. Brian Kemp gave a strong show of support to the Georgia Research Alliance (GRA) Thursday. But the nonprofit organization launched in 1990 with seed money from the state to grow Georgia’s technology industry still will be subject to same budget cuts Kemp has ordered for state agencies. The governor told members of the GRA board…

Read More

Largest Real-World Study of Immunotherapy Shows Men with Advanced Prostate Cancer with Low PSA had a Median Survival of Nearly Four Years after Treatment with PROVENGE® (sipuleucel-T)

– Data from Nearly 2,000 Patients Finds that Men Treated with PROVENGE when Baseline PSA was <5.27 ng/mL Lived 47.7 Months – – Findings Consistent with Pivotal IMPACT Trial – September 04, 2019 01:15 PM Eastern Daylight Time SEAL BEACH, Calif.–(BUSINESS WIRE)–Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today…

Read More

GeoVax Announces Publication of Lassa Fever Vaccine Study Results

100% Single-Dose Protection Observed in Lethal Challenge Model ATLANTA, GA, September 4, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its article entitled “A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge.” The paper appears in the open…

Read More